Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The Journal of Heart and Lung Transplantation

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.healun.2008.07.013PMID 18926396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 303: Hemodynamic Compromise Rejection: Does the Heart Biopsy Influence Outcome?

  2008cited by this paper
• Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.

  2007cited by this paper
• Antibody and complement in transplant vasculopathy.

  2007cited by this paper
• Anti‐HLA alloantibodies in pediatric solid organ transplantation

  2006cited by this paper
• Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin

  2006cited by this paper
• Holding T cells in check--a new role for complement regulators?

  2006cited by this paper
• Acute antibody-mediated rejection of cardiac transplants.

  2006cited by this paper
• Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

  2005cited by this paper
• The distribution of cardiac macrophages in myocardial ischaemia and cardiomyopathy

  2005cited by this paper
• Antibody‐Mediated Rejection in Human Cardiac Allografts: Evaluation of Immunoglobulins and Complement Activation Products C4d and C3d as Markers

  2005cited by this paper
• Cardiac retransplantation in childhood: analysis of data from the United Network for Organ Sharing.

  2005cited by this paper
• Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.

  2005cited by this paper
• Humoral Heart Rejection (Severe Allograft Dysfunction with no Signs of Cellular Rejection or Ischemia): Incidence, Management, and the Value of C4d for Diagnosis

  2005cited by this paper
• Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy

  2005cited by this paper
• Non‐Complement‐ and Complement‐Activating Antibodies Synergize to Cause Rejection of Cardiac Allografts

  2004cited by this paper
• National Conference to Assess Antibody‐Mediated Rejection in Solid Organ Transplantation

  2004cited by this paper
• Acute Vascular Rejection and Accommodation: Divergent Outcomes of the Humoral Response to Organ Transplantation

  2004cited by this paper
• Immunoperoxidase Staining for C4d on Paraffin-embedded Tissue in Cardiac Allograft Endomyocardial Biopsies: Comparison to Frozen Tissue Immunofluorescence

  2004cited by this paper
• Non-ischemic left ventricular dysfunction after pediatric cardiac transplantation: treatment with plasmapheresis and OKT3.

  2004cited by this paper
• Pediatric cardiac transplantation in children with high panel reactive antibody.

  2004cited by this paper
• Pre‐exposure to sub‐saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement‐mediated lysis by regulating Bad through the phosphatidylinositol 3‐kinase/Akt pathway

  2004cited by this paper
• Fulminant mixed humoral and cellular rejection in a cardiac transplant recipient: a review of the histologic findings and literature.

  2003cited by this paper
• HLA alloimmunization in patients requiring ventricular assist device support.

  2002cited by this paper
• Generation of C-reactive protein and complement components in atherosclerotic plaques.

  2001cited by this paper
• Complement as a mediator of vascular inflammation and activation in allografts.

  2000cited by this paper
• Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients.

  2000cited by this paper
• Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies.

  1999cited by this paper
• Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes.

  1999cited by this paper
• Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation.

  1999cited by this paper
• In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies.

  1996cited by this paper
• Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression.

  1994cited by this paper
• Renal transplantation following immunoadsorption in highly sensitized recipients.

  1993cited by this paper
• Complement activation induces the expression of decay-accelerating factor on human mesangial cells.

  1991cited by this paper

• Cellular Rejection Post-Cardiac Transplantation: A 13-Year Single Unicentric Study

  2025cites this paper
• Pathology of Antibody-Mediated Rejection

  2016cites this paper
• Pathology of Pediatric Heart Transplantation

  2016cites this paper
• Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association.

  2015cites this paper
• Increased macrophage density of cardiac allograft biopsies is associated with antibody‐mediated rejection and alloantibodies to HLA antigens

  2014cites this paper
• Donor‐specific antibodies: Can they predict C4d deposition in pediatric heart recipients?

  2013cites this paper
• The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation.

  2013cites this paper
• New tissue biomarkers of Antibody Mediated Rejection in Heart Transplantation

  2012cites this paper
• The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011).

  2011cites this paper
• Very Late Heart Transplant Rejection Is Associated with Microvascular Injury, Complement Deposition and Progression to Cardiac Allograft Vasculopathy

  2011cites this paper
• Role of C3d and C4d complement fragments in the diagnostics of acute allograft rejection after transplantations.

  2009cites this paper
• Utility of routine immunofluorescence staining for C4d in cardiac transplant recipients.

  2009cites this paper
• Aha Scientific Statement Antibody-mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management a Scientific Statement from the American Heart Association Endorsed by the International Society for Heart and Lung Transplantation

  year unknowncites this paper